| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_246f69b514c63b4804cf042e702632b6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2013-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c35f8a5fa91abbfea0bbab53765f823
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a35ac3e450271c43036bb4b376df3f17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_365bb974d97690bc7fd76df44aa33885 |
| publicationDate |
2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112015006642-B1 |
| titleOfInvention |
PROLONGED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING METHADOXINE AND PREDNISONE |
| abstract |
METHADOXINE, PHARMACEUTICAL COMPOSITION AND PROLONGED RELEASE PHARMACEUTICAL COMPOSITION. The invention relates to the use of metadoxine in the prevention and treatment of non-alcoholic fatty liver disease (NAFLC) and non-alcoholic steatohepatitis (NASH), in improving the survival rate of patients with various alcoholic hepatitis and for new formulations. extended-release pharmaceuticals comprising metadoxine. |
| priorityDate |
2012-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |